Clarus Therapeutics Archives

Press ESC key to close search

RBC Capital Markets Advises Tolmar on Acquisition of JATENZO from Clarus Therapeutics

Tolmar Pharmaceuticals, a fully integrated pharmaceutical company, through its affiliate, Tolmar, acquired of all rights to JATENZO from Clarus Therapeutics Holdings and its wholly-owned subsidiary Clarus Therapeutics.

Clarus Therapeutics Files for Chapter 11

Clarus Therapeutics, together with its wholly-owned subsidiary Clarus Therapeutics, has filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Clarus Therapeutics

RBC Capital Markets Advises Tolmar on Acquisition of JATENZO from Clarus Therapeutics

Clarus Therapeutics Files for Chapter 11